1. A role for TASK2 channels in the human immunological synapse. Issue 2 (18th December 2020) Authors: Fernández‐Orth, Juncal; Rolfes, Leoni; Gola, Lukas; Bittner, Stefan; Andronic, Joseph; Sukhorukov, Vladimir L.; Sisario, Dmitri; Landgraf, Peter; Dieterich, Daniela C.; Cerina, Manuela; Smalla, Karl‐Heinz; Kähne, Thilo; Budde, Thomas; Kovac, Stjepana; Ruck, Tobias; Sauer, Markus; Meuth, Sven G. Journal: European journal of immunology Issue: Volume 51:Issue 2(2021) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Issue 3 (14th July 2021) Authors: Rolfes, Leoni; Schulte-Mecklenbeck, Andreas; Schreiber, Stefanie; Vielhaber, Stefan; Herty, Michael; Marten, Anika; Pfeuffer, Steffen; Ruck, Tobias; Wiendl, Heinz; Gross, Catharina C; Meuth, Sven G; Boentert, Matthias; Pawlitzki, Marc Journal: Brain communications Issue: Volume 3:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study. (December 2022) Authors: Pape, Katrin; Rolfes, Leoni; Steffen, Falk; Muthuraman, Muthuraman; Korsen, Melanie; Meuth, Sven G.; Zipp, Frauke; Bittner, Stefan Journal: Therapeutic advances in neurological disorders Issue: Volume 15(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement?. (12th January 2021) Authors: Pawlitzki, Marc; Ahring, Sigrid; Rolfes, Leoni; Dziewas, Rainer; Warnecke, Tobias; Suntrup‐Krueger, Sonja; Wiendl, Heinz; Klotz, Luisa; Meuth, Sven G.; Labeit, Bendix Journal: European journal of neurology Issue: Volume 28:Number 5(2021) Page Start: 1765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres. (February 2022) Authors: Pfeuffer, Steffen; Rolfes, Leoni; Hackert, Jana; Kleinschnitz, Konstanze; Ruck, Tobias; Wiendl, Heinz; Klotz, Luisa; Kleinschnitz, Christoph; Meuth, Sven G; Pul, Refik Journal: Multiple sclerosis Issue: Volume 28:Number 2(2022) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis. Issue 6 (19th November 2021) Authors: Eschborn, Melanie; Pawlitzki, Marc; Wirth, Timo; Nelke, Christopher; Pfeuffer, Steffen; Schulte-Mecklenbeck, Andreas; Lohmann, Lisa; Rolfes, Leoni; Pape, Katrin; Eveslage, Maria; Bittner, Stefan; Gross, Catharina C.; Ruck, Tobias; Wiendl, Heinz; Meuth, Sven G.; Klotz, Luisa Journal: Neurology Issue: Volume 8:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis. Issue 6 (November 2021) Authors: Eschborn, Melanie; Pawlitzki, Marc; Wirth, Timo; Nelke, Christopher; Pfeuffer, Steffen; Schulte-Mecklenbeck, Andreas; Lohmann, Lisa; Rolfes, Leoni; Pape, Katrin; Eveslage, Maria; Bittner, Stefan; Gross, Catharina C.; Ruck, Tobias; Wiendl, Heinz; Meuth, Sven G.; Klotz, Luisa Journal: Neurology Issue: Volume 8:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab. Issue 9 (22nd February 2022) Authors: Räuber, Saskia; Korsen, Melanie; Huntemann, Niklas; Rolfes, Leoni; Müntefering, Thomas; Dobelmann, Vera; Hermann, Alexander M; Kölsche, Tristan; von Wnuck Lipinski, Karin; Schroeter, Christina B; Nelke, Christopher; Regner-Nelke, Liesa; Ingwersen, Jens; Pawlitzki, Marc; Teegen, Bianca; Barnett, M... Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 9(2022) Page Start: 978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab. Issue 9 (12th March 2021) Authors: Pfeuffer, Steffen; Ruck, Tobias; Pul, Refik; Rolfes, Leoni; Korsukewitz, Catharina; Pawlitzki, Marc; Wildemann, Brigitte; Klotz, Luisa; Kleinschnitz, Christoph; Scalfari, Antonio; Wiendl, Heinz; Meuth, Sven G Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 92:Issue 9(2021) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19. Issue 5 (September 2021) Authors: Rolfes, Leoni; Pawlitzki, Marc; Pfeuffer, Steffen; Nelke, Christopher; Lux, Anke; Pul, Refik; Kleinschnitz, Christoph; Kleinschnitz, Konstanze; Rogall, Rebeca; Pape, Katrin; Bittner, Stefan; Zipp, Frauke; Warnke, Clemens; Goereci, Yasemin; Schroeter, Michael; Ingwersen, Jens; Aktas, Orhan; Klotz,... Journal: Neurology Issue: Volume 8:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗